Martin E Sanders

USPTO Granted Patents = 51 (Patent Applications = 20)

CIPO Patents = 4 (Patent Applications = 7)

EPO Patents = 4 (Patent Applications = 6)

Average Co-Inventor Count = 2.1

ph-index = 9

Forward Citations = 221(Granted Patents)

Forward Citations (Not Self Cited) = 50(Oct 12, 2025)

Location History:

San Juan Capistrano, CA (US) (2018)
Santa Ana, CA (US) (2020)
Seattle, WA (US) (2018 - 2023)
Spring, TX (US) (2023 - 2024)

Company Filing History:

49 out of 72

Io Therapeutics, Inc.

patents

3 out of 5,444

University of Texas System

patents

2 out of 3

Lo Therapeutics, Inc.

where one patent can have more than one assignee

Years Active: 2018-2025

Loading Chart...

51 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12383521 - Treatment of diseases by concurrently eliciting remyelination effects and immunomodulatory effects using selective RXR agonists (2025-08-12),

2. 12325685 - RXR agonist salt form, polymorphs thereof, and uses thereof (2025-06-10),

3. 12115193 - Methods of using RARγ agonists for cancer treatment (2024-10-15),

4. 11998521 - Use of an RXR agonist in treating drug resistant HER2+ cancers (2024-06-04),

5. 11919848 - RXR agonist salt form, polymorphs thereof, and uses thereof (2024-03-05),

6. 11896558 - Use of an RXR agonist and taxanes in treating Her2+ cancers (2024-02-13),

7. 11793835 - Methods of using RARγ agonists for cancer treatment (2023-10-24),

8. 11786555 - RAR selective agonists in combination with immune modulators for cancer immunotherapy (2023-10-17),

9. 11779558 - Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy (2023-10-10),

10. 11737996 - Immunomodulatory and differentiating function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy (2023-08-29),

11. 11690832 - Treatment of autoimmune diseases with combinations of RXR agonists and thyroid hormones (2023-07-04),

12. 11690831 - Treatment of autoimmune diseases with combinations of RXR agonists and thyroid hormones (2023-07-04),

13. 11648223 - Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy (2023-05-16),

14. 11517549 - Treatment of disease with esters of selective RXR agonists (2022-12-06),

15. 11224583 - Use of an RXR agonist in treating HER2+ cancers (2022-01-18),

Title: The Innovative Journey of Martin E Sanders

Introduction: Martin E Sanders, a visionary inventor based in Seattle, WA, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Martin E Sanders holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and innovative spirit.

Career Highlights: With a career spanning over two decades, Martin E Sanders has worked tirelessly to bring his ideas to life. His inventions have revolutionized various industries, earning him recognition as a pioneer in the field of innovation.

Collaborations: Throughout his career, Martin E Sanders has collaborated with leading research institutions, universities, and tech companies to further develop and commercialize his inventions. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: Martin E Sanders continues to push the boundaries of innovation, with a relentless drive to create solutions that have a positive impact on society. His passion for invention and dedication to excellence make him a true trailblazer in the world of technology.

This text is generated by artificial intelligence and may not be accurate.